The post CME’s Solana and XRP Futures Hit $3B as PEPENODE Hits $2M with Mine-to-Earn Coin appeared on BitcoinEthereumNews.com. Solana and XRP futures are now CME’s fastest-growing crypto products, highlighting a shift toward scalable altcoin infrastructure. KEY POINTS:➡️ Solana and XRP futures are the hottest crypto products on CME, reaching over $3B in outstanding contracts.➡️ Market maturity, infrastructure developments, and softer crypto regulations are driving this trend.➡️ Meanwhile, the viral Solana meme coin, PEPENODE, hit $2M raised in its hot presale, sparking FOMO with its mine-to-earn model. Crypto products tied to Solana and XRP on CME reached a new milestone on Monday, surpassing $3B in ppen interest. The derivatives giant began offering Bitcoin futures in 2017 – a bold step at a time when crypto ETFs didn’t exist and regulatory frameworks were uncertain. It took a long time for CME to expand its lineup beyond $BTC and $ETH, finally adding other cryptocurrencies like Solana and XRP earlier this year. Source: CME Group In August, both products crossed $1B in outstanding contracts, with XRP futures first to reach the milestone. But over the next 18 days, the notional value of open interest for Solana futures nearly doubled. What’s more, Solana futures have seen an average daily volume of $700M in October, despite market jitters. What’s Behind this Surge in Activity? CME’s regulated platform gives users exposure to popular cryptocurrencies through derivatives – without the complications of directly holding the underlying tokens. If anything, the deleveraging event of Oct 10 serves as a reminder of why regulated platforms and structured frameworks like CME’s matter. According to Giovanni Vicioso, CME Group’s global head of cryptocurrency products, the XRP and Solana offerings  ‘were able to benefit from the learnings that we saw in the marketplace with the launch of Bitcoin and Ethereum.’ While XRP and Solana futures have clearly built upon the foundation laid by previous products, growing regulatory clarity has also been… The post CME’s Solana and XRP Futures Hit $3B as PEPENODE Hits $2M with Mine-to-Earn Coin appeared on BitcoinEthereumNews.com. Solana and XRP futures are now CME’s fastest-growing crypto products, highlighting a shift toward scalable altcoin infrastructure. KEY POINTS:➡️ Solana and XRP futures are the hottest crypto products on CME, reaching over $3B in outstanding contracts.➡️ Market maturity, infrastructure developments, and softer crypto regulations are driving this trend.➡️ Meanwhile, the viral Solana meme coin, PEPENODE, hit $2M raised in its hot presale, sparking FOMO with its mine-to-earn model. Crypto products tied to Solana and XRP on CME reached a new milestone on Monday, surpassing $3B in ppen interest. The derivatives giant began offering Bitcoin futures in 2017 – a bold step at a time when crypto ETFs didn’t exist and regulatory frameworks were uncertain. It took a long time for CME to expand its lineup beyond $BTC and $ETH, finally adding other cryptocurrencies like Solana and XRP earlier this year. Source: CME Group In August, both products crossed $1B in outstanding contracts, with XRP futures first to reach the milestone. But over the next 18 days, the notional value of open interest for Solana futures nearly doubled. What’s more, Solana futures have seen an average daily volume of $700M in October, despite market jitters. What’s Behind this Surge in Activity? CME’s regulated platform gives users exposure to popular cryptocurrencies through derivatives – without the complications of directly holding the underlying tokens. If anything, the deleveraging event of Oct 10 serves as a reminder of why regulated platforms and structured frameworks like CME’s matter. According to Giovanni Vicioso, CME Group’s global head of cryptocurrency products, the XRP and Solana offerings  ‘were able to benefit from the learnings that we saw in the marketplace with the launch of Bitcoin and Ethereum.’ While XRP and Solana futures have clearly built upon the foundation laid by previous products, growing regulatory clarity has also been…

CME’s Solana and XRP Futures Hit $3B as PEPENODE Hits $2M with Mine-to-Earn Coin

Solana and XRP futures are now CME’s fastest-growing crypto products, highlighting a shift toward scalable altcoin infrastructure.

KEY POINTS:
➡️ Solana and XRP futures are the hottest crypto products on CME, reaching over $3B in outstanding contracts.
➡️ Market maturity, infrastructure developments, and softer crypto regulations are driving this trend.
➡️ Meanwhile, the viral Solana meme coin, PEPENODE, hit $2M raised in its hot presale, sparking FOMO with its mine-to-earn model.

Crypto products tied to Solana and XRP on CME reached a new milestone on Monday, surpassing $3B in ppen interest.

The derivatives giant began offering Bitcoin futures in 2017 – a bold step at a time when crypto ETFs didn’t exist and regulatory frameworks were uncertain.

It took a long time for CME to expand its lineup beyond $BTC and $ETH, finally adding other cryptocurrencies like Solana and XRP earlier this year.

Source: CME Group

In August, both products crossed $1B in outstanding contracts, with XRP futures first to reach the milestone. But over the next 18 days, the notional value of open interest for Solana futures nearly doubled.

What’s more, Solana futures have seen an average daily volume of $700M in October, despite market jitters.

What’s Behind this Surge in Activity?

CME’s regulated platform gives users exposure to popular cryptocurrencies through derivatives – without the complications of directly holding the underlying tokens.

If anything, the deleveraging event of Oct 10 serves as a reminder of why regulated platforms and structured frameworks like CME’s matter.

According to Giovanni Vicioso, CME Group’s global head of cryptocurrency products, the XRP and Solana offerings  ‘were able to benefit from the learnings that we saw in the marketplace with the launch of Bitcoin and Ethereum.’

While XRP and Solana futures have clearly built upon the foundation laid by previous products, growing regulatory clarity has also been a crucial factor, attracting more players to the cryptocurrency market.

Source: CME Group on X

The recent introduction of XRP and Solana ETFs has further accelerated the trend, creating a stronger two-way flow between the regulated spot and futures markets.

This is because ETFs are attracting traditional players who previously wouldn’t touch crypto. They’ve made it easier to run basis and arbitrage trades between ETFs and CME futures, bypassing crypto wallets and exchanges.

As futures volumes climb and open interest surges, traders are seeking speed, liquidity, and credible alternatives to legacy chains.

PEPENODE’s presale taps into that shift. With early traction and a clear use case as a viable crypto-mining alternative, Pepenode positions itself as a retail-accessible complement to the institutional surge.

Solana Meme Coin PEPENODE Crosses $2M in Viral Presale

PEPENODE ($PEPENODE) is rapidly becoming one of the hottest meme coin presales this season.

The Solana-based project is building a mine-to-earn platform that provides investors with thrilling, gamified ways to generate passive income.

While crypto mining has long been inaccessible to everyday traders, PEPENODE changes this. It removes the technical and financial entry barriers to crypto mining by replacing expensive mining rigs with a virtual mining simulator that runs on-chain.

Using the native $PEPENODE token, anyone can purchase digital mining nodes and set up their own virtual server room.

  • Each node has unique features and mining power.
  • To maximize your earning potential, you mix and match nodes.
  • You can also upgrade facilities to optimize your mining setup.
  • Your earning potential grows in proportion to your hash rate.
  • $PEPENODE tokens are used to make all payments and rewards on the network.

Top players are also eligible for airdrops in popular meme coins like $PEPE and $FARTCOIN. In addition, a referral program lets referrers earn 2% mining rewards.

Since 70% of all tokens used for upgrades are burnt, presale participants have a unique edge in the community. The earlier you buy the token during the presale phase, the more its value grows over time, given the declining total supply.

The discounted presale prices and generous staking rewards add to the presale appeal.

However, investors must act promptly to secure the token at its current discounted price of just $0.0011272, as the next price rise is scheduled for just two days’ time. The staking APY will also decline as more investors join in.

Visit the PEPENODE website to join the presale and stake now for 640% APY.

Disclaimer: This content has been supplied by a third party contributor. Brave New Coin does not endorse or promote any products or services mentioned herein. Readers are encouraged to conduct independent research before making any financial decisions. The information provided is for informational and educational purposes only and should not be interpreted as investment advice.

Source: https://bravenewcoin.com/partner/cme-solana-and-xrp-futures-hit-3b-as-pepenode-hits-2m

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.4229
$1.4229$1.4229
-1.60%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26